Pharmaceutical and Healthcare Sciences Society (PHSS) Sterile Product Conference 2025

Pharmaceutical and Healthcare Sciences Society (PHSS) Sterile Product Conference 2025 is organized by The Pharmaceutical & Healthcare Sciences Society (PHSS) and will be held from Jun 25 - 26, 2025 at AstraZeneca, Macclesfield, England, United Kingdom.

Description:
This major PHSS conference will address the key challenges in sterile product manufacture and processing of intermediates that require low bioburden control following risk-based initiatives from a regulatory, Pharmaceutical/Biopharmaceutical industry, and healthcare pharmacy perspective. AstraZeneca will offer a site tour on the afternoon of June 25th, and we will meet for a networking dinner at Shrigley Hall.

Sterile Product Conference for Pharmaceuticals, Biotech, and New Technologies

Join us for a key industry event focused on the latest advancements in sterile product manufacturing, including pharmaceutical, biotech, and new technology developments. This conference will provide valuable insights from leading experts and offer networking opportunities with industry professionals and NHS representatives.

Agenda Highlights:

• Welcome and Opening – A warm welcome and health & safety briefing hosted by AstraZeneca.
• MHRA Presenting – Insightful presentation from MHRA (TBC).
• Data-Driven Sterile Manufacturing – Paul Parsons (AstraZeneca) - Explore how data transforms sterile manufacturing processes.
• Sterility Assurance – Darren Jones ExPharmaceutical Inspectors Consortium Ltd will review current failure modes and root causes in sterility assurance.
• Decentralised Manufacturing – Ian Rees - MHRA will provide the latest information on point of care and modular manufacturing. The legislation was amended (Statutory Instrument 2025 87) on January 23rd and comes into effect on July 23rd, 2025. This has challenges for the manufacture of sterile products.
• UVD Robot for Cleanroom Disinfection – Andrew Gravett (AstraZeneca) - Learn about autonomous UV-C technology for enhanced contamination control.
• Upgrade Journey for Sterile and Non-Sterile Suites – Kirsten Heukelbach - Hammersmith Medicines Research shares strategies for facility improvements.
• Round Table Discussion – Engage with industry experts to reflect on key takeaways and future trends.

This is a must-attend event for sterile manufacturing, biotech, and healthcare professionals. Connect with peers, gain actionable insights, and stay ahead in an evolving regulatory landscape.